Gurushanthaiah Keerti MD is categorized under Physicians Offices in San Diego, CA and active since 2007.
Gurushanthaiah Keerti MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Keerti Gurushanthaiah at the company’s single location by writing to 9339 Genesee Avenue # 220, San Diego, California CA 92121 or by phoning (858) 455-7520. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Gurushanthaiah Keerti MD |
Contact Person: | Keerti Gurushanthaiah |
Address: | 9339 Genesee Avenue # 220, San Diego, California 92121 |
Phone Number: | (858) 455-7520 |
Website Address: | igomed.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Physicians Offices |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Gurushanthaiah Keerti MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Keerti Gurushanthaiah for inquiries that concern Gurushanthaiah Keerti MD by calling the company number (858) 455-7520, as your correspondence is most welcome. Additionally, the physical location of the single location of Gurushanthaiah Keerti MD can be found at the coordinates 32.87589,-117.21388 as well as the street address 9339 Genesee Avenue # 220 in San Diego, California 92121.
For its online presence, you may visit Gurushanthaiah Keerti MD’s website at igomed.com and engage with its social media outlets through on Twitter and on Facebook.